| Janssen-Cilag AG - Darzalex 400mg/20ml, Konzentrat zur Herstellung einer Infusionslösung |
| 66072 | | 02 | | Darzalex 400mg/20ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FC01 | | | | 06.12.2016 | | |
|
| Composition |
| daratumumabum 400 mg, acidum aceticum glaciale, natrii acetas trihydricus, natrii chloridum, mannitolum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 37.7 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Daratumumabum | 400mg / 20ml |
| | BAG: Active Agent | Dose |
|---|
| Daratumumabum | 400 mg |
| | | | Inactive agents |
|---|
| Acidum Aceticum Glaciale | | Mannitol | | Sodium Acetate Trihydrate | | Sodium Chloride | | Polysorbatum 20 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
